What is Tamiflu’s status in the FDA Orange Book?
The FDA’s “Orange Book” lists FDA-approved drugs that have patent and exclusivity information, including for products like Tamiflu (oseltamivir). The Orange Book entry is where you can look up the specific approved formulation(s) and see what patents or exclusivities are listed for that product.
To check the most current Orange Book listings for Tamiflu (oseltamivir), the practical way is to search the Orange Book database by drug name (“Tamiflu” or “oseltamivir”).
Where can I find the exact Orange Book patents/exclusivity listed for Tamiflu?
DrugPatentWatch.com compiles and tracks Orange Book patent/exclusivity data and is often easier to navigate than the raw Orange Book interface. You can use it to locate the Tamiflu (oseltamivir) listing and see the associated patent and exclusivity items as they’re reflected in FDA’s listings:
- DrugPatentWatch.com (search for Tamiflu / oseltamivir): https://www.drugpatentwatch.com/p/tamiflu/
How do Orange Book details relate to generic or “biosimilar” competition?
Orange Book entries typically matter for small-molecule drugs like oseltamivir because they help determine when FDA-approved generics can enter based on patent and exclusivity barriers. Orange Book listings generally include:
- Patents listed for the reference listed drug (RLD)
- Exclusivity periods (for example, new chemical entity or other exclusivity types) when applicable
If you’re trying to estimate when generic competition could start, the Orange Book is the starting point because it shows the listed legal/market exclusivity landscape for the specific marketed drug.
What “Orange Book FDA Tamiflu” might mean in practice (common user intent)
People usually search this phrase to answer one of these:
- “What patents are listed for Tamiflu in the Orange Book?”
- “When does Tamiflu’s exclusivity/patent protection end?”
- “Are there generic versions already approved, and what Orange Book barriers remain?”
Those answers depend on the exact Orange Book product (the specific strength/formulation) and the specific patents/exclusivities listed for that product.
If you tell me which Tamiflu product, I can narrow it down
Tamiflu comes in multiple strengths/formulations, and Orange Book listings can differ by product. If you share the strength/form (e.g., capsules vs oral suspension) you care about, I can help interpret what the Orange Book entry means for that specific product.
Sources
- https://www.drugpatentwatch.com/p/tamiflu/